5 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18516589 | EGFR Degraders to Treat Cancer Metastasis to the Brain or CNS | ELENISTE, PIERRE PAUL | 1622 | Non-Final OA | Nov 21, 2023 |
| 18289438 | COMPOUNDS FOR TARGETING DEGRADATION OF BRUTON'S TYROSINE KINASE | SHIAO, REI TSANG | 1691 | Non-Final OA | Nov 03, 2023 |
| 18385277 | GLUTARIMIDES FOR MEDICAL TREATMENT | HIRAKIS, SOPHIA P | 1623 | Final Rejection | Oct 30, 2023 |
| 17771204 | BIFUNCTIONAL COMPOUNDS FOR THE TREATMENT OF CANCER | ENGLISH, CONNOR KENNEDY | 1625 | Non-Final OA | Apr 22, 2022 |
| 17723199 | TRICYCLIC DEGRADERS OF IKAROS AND AIOLOS | HIRAKIS, SOPHIA P | 1623 | Non-Final OA | Apr 18, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial